Medical Services International Develops Next Generation Malaria Test Kit
26 Avril 2006 - 6:57PM
PR Newswire (US)
EDMONTON, Alberta, April 26 /PRNewswire-FirstCall/ -- Medical
Services International Inc. (OTC:MSITF) is pleased to announce that
it has completed testing and the test kit is ready for the market
on its latest development of the VScan Malaria test kit. There are
four types of malaria that are caused by four types of parasites.
Historically existing test kits in the marketplace tested
exclusively for the most common form of malaria caused by the
Plasmodium Falciparium parasite. The newly developed VScan Malaria
rapid test kit, tests for all four types of malaria. There are no
other rapid test kits currently available that tests for all 4
types of malaria. Due to this concentration on only the one type of
malaria the other three types have been able to develop and spread.
Malaria is spread by the mosquito. The significance of malaria as a
health problem is increasing in many parts of the world. Epidemics
are occurring in many parts of the world (Africa, Southeast Asia,
Central America) outside areas that are usually associated with
Malaria. The main victims are rural populations. Malaria is complex
but it is a curable and preventable disease if detected early and
given adequate treatment. The new VScan rapid test kit for
detecting all types of Malaria will be instrumental in reducing the
incidence of malaria in many parts of the world. It is anticipated
that based on market studies and current interest in the new
malaria test kit that the company will sell in excess of 500,000
malaria test kits this year. About VScan The VScan rapid test kit
is a single use, easy to use, test for the screening of HIV
1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West
Nile, Syphilis, and Prostate Cancer. The kits cannot be used in
Canada. Medical Services International Inc. trades in the United
States on the NQB Pinksheets under the symbol "MSITF". For further
information, please contact Robert Talbot at (780) 430 6363 or
http://www.medicalservicesintl.com/ or
http://www.minerva-biotech.com/ . NOTE: Certain statements in this
press release are "forward-looking statements" within the meaning
of the Private Securities Act of 1995. Such statements involve
known and unknown risks, uncertainties and other factors that may
cause results to differ materially. Such risks, uncertainties and
other factors include but are not limited to new economic
conditions, risk in product development, market acceptance of new
products and continuing product demand, level of competition and
other factors described in Company reports and other filings with
regulatory bodies. DATASOURCE: Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,
+1-780-430 6363 Web site: http://www.medicalservicesintl.com/
http://www.minerva-biotech.com/
Copyright